These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 23764400)

  • 1. Suppression of T cell-induced osteoclast formation.
    Karieb S; Fox SW
    Biochem Biophys Res Commun; 2013 Jul; 436(4):619-24. PubMed ID: 23764400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression.
    Karieb S; Fox SW
    J Cell Biochem; 2011 Feb; 112(2):476-87. PubMed ID: 21268069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
    Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
    Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
    Karieb S; Fox SW
    Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
    Weitzmann MN; Cenci S; Rifas L; Haug J; Dipersio J; Pacifici R
    J Bone Miner Res; 2001 Feb; 16(2):328-37. PubMed ID: 11204433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of osteoclastogenesis and osteoclast function by apigenin.
    Bandyopadhyay S; Lion JM; Mentaverri R; Ricupero DA; Kamel S; Romero JR; Chattopadhyay N
    Biochem Pharmacol; 2006 Jul; 72(2):184-97. PubMed ID: 16750176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
    Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N
    Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A; Kudo O; Athanasou NA
    J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated T lymphocytes support osteoclast formation in vitro.
    Horwood NJ; Kartsogiannis V; Quinn JM; Romas E; Martin TJ; Gillespie MT
    Biochem Biophys Res Commun; 1999 Nov; 265(1):144-50. PubMed ID: 10548505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
    Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
    Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
    Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
    J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein and coumestrol reduce MCF-7 breast cancer cell viability and inhibit markers of preferential metastasis, bone matrix attachment and tumor-induced osteoclastogenesis.
    Al-Thamiree Mezban S; Fox SW
    Arch Biochem Biophys; 2023 May; 740():109583. PubMed ID: 36967033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.
    Oostlander AE; Everts V; Schoenmaker T; Bravenboer N; van Vliet SJ; van Bodegraven AA; Lips P; de Vries TJ
    J Cell Biochem; 2012 Jan; 113(1):260-8. PubMed ID: 21898548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.